Gems Pharmaceuticals Private Limited
About Gems Pharmaceuticals Private Limited
Data last updated:
Gems Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 December 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U52311BR1995PTC006914. Its GSTIN is 10AABCG4964D1Z3 (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Lal Babu Singh (Whole-Time Director) and Ratan Kumar Jha (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 3rd Floor Sharda Lok Sandalpur Road Kumhrar, Patna, Bihar, India – 800006.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.97 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹6.28 Lakh (net margin 3.2%) and EBITDA of ₹10 Lakh (EBITDA margin 5.1%). Revenue has declined at a compounded annual rate (CAGR) of 2% over five years.
As per MCA filings, the company has satisfied charges of ₹28.5 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Gems Pharmaceuticals has one previous CIN (Corporate Identification Number): U99999BR9999PLC006914. The current CIN is U52311BR1995PTC006914, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U52311BR1995PTC006914 | Current |
| U99999BR9999PLC006914 | Previous |
Contact details
Gems Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3rd Floor Sharda Lok Sandalpur Road Kumhrar, Patna, Bihar, India – 800006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Gems Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gems Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Gems Pharmaceuticals Private Limited, buy the company report.
Financials of Gems Pharmaceuticals Private Limited
FY 2023 filings availableGems Pharmaceuticals Private Limited reported revenue of ₹1.97 Cr (down 14% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 14% fall in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gems Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gems Pharmaceuticals Private Limited
Gems Pharmaceuticals has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashmi Kumari Also directs: Baijnath Distributors Private Limited | Director | 01 Apr 2015 | 11 Years 7 Months | Current |
| Lal Babu Singh | Whole-Time Director | 14 Dec 1995 | 30 Years 11 Months | Current |
| Ratan Kumar Jha | Whole-Time Director | 01 Oct 1996 | 30 Years 1 Months | Current |
| Jai Babu Sharma | Whole-Time Director | 01 Mar 2013 | 13 Years 8 Months | Current |
Peer comparison
Gems Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Omenta Pharma Private Limited. | ₹1.98 Cr (FY 2025) | 28.0% | Delhi, India | |||
| Praxis Health Care & Pharmaceuticals Private Limited | ₹1.98 Cr (FY 2024) | -2.0% | Jaipur, Rajasthan, India | |||
| Afloat Pharma Private Limited | ₹1.98 Cr (FY 2024) | 6.0% | Bilaspur, Chhattisgarh, India | |||
| Vignesh Health Care Private Limited | ₹1.98 Cr (FY 2024) | 934.0% | Bangalore, Karnataka, India | |||
| Gems Pharmaceuticals Private Limitedthis company | ₹1.97 Cr (FY 2023) | ₹6.28 Lakh | 3.2% | -14.0% | Patna, Bihar, India | |
| Piyatho Health Care Private Limited | ₹1.97 Cr (FY 2024) | 206.0% | Ernakulam, Kerala, India | |||
| R.S.Pathy Naturo Private Limited | ₹1.97 Cr (FY 2025) | -6.0% | Madurai, Tamil Nadu, India |
To see the full peer comparison of Gems Pharmaceuticals Private Limited, buy the company report.
Auditor
Gems Pharmaceuticals Private Limited is audited by P JYOTI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P JYOTI & CO | FY 2022 | 010237C |
Shareholding
The shareholding of Gems Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gems Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Nov 1997 | 90264218 | Central Bank of India | ₹28.5 Lakh | Satisfied |
To see the full charge records of Gems Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Gems Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Gems Pharmaceuticals. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (MJC) | Filed by the company against individuals | Disposed |
| High Court | Interim or miscellaneous application | Filed by the company against individuals | Disposed |
To see the full case history of Gems Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gems Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gems Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AABCG4964D1Z3 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gems Pharmaceuticals Private Limited, buy the company report.
Recent activity
Gems Pharmaceuticals Private Limited has 15 board changes on record since 1995: 4 appointments and 11 cessations. The latest: Rashmi Kumari ceased to be Additional Director on 30 Sep 2015.
9 earlier events are in the company report.
Frequently asked questions
Gems Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 December 1995 (31+ years old) and is registered under CIN U52311BR1995PTC006914.
Gems Pharmaceuticals has 4 current directors:
- Lal Babu Singh - Whole-Time Director
- Ratan Kumar Jha - Whole-Time Director
- Jai Babu Sharma - Whole-Time Director
- Rashmi Kumari - Director
The latest financial statements of Gems Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Gems Pharmaceuticals is 10AABCG4964D1Z3, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Gems Pharmaceuticals is U52311BR1995PTC006914. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gems Pharmaceuticals has 2 court cases on record: 2 filed by the company.
Gems Pharmaceuticals was incorporated on 14 December 1995, making it 31+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Gems Pharmaceuticals by revenue are Omenta Pharma Private Limited, Praxis Health Care & Pharmaceuticals Private Limited, Afloat Pharma Private Limited, Vignesh Health Care Private Limited, Piyatho Health Care Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Rashmi Kumari ceased to be Additional Director on 30 Sep 2015. Parsan Kumar Singh ceased to be Whole-Time Director on 01 Apr 2015. Rashmi Kumari was appointed as Director on 01 Apr 2015. Gems Pharmaceuticals has 15 board changes on record in total.
The registered office of Gems Pharmaceuticals is at 3rd Floor Sharda Lok Sandalpur Road Kumhrar, Patna, Bihar, India – 800006.
Gems Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
